Jianmin Pharmaceutical Group Co Ltd (600976) — Cash Flow Reinvestment Rate
Jianmin Pharmaceutical Group Co Ltd (600976) has a Cash Flow Reinvestment Rate of 0.36x as of December 2025, reinvesting CN¥38.21 Million (capex CN¥23.23 Million plus investments CN¥-14.98 Million) from operating cash flow of CN¥106.82 Million. See 600976 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jianmin Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Jianmin Pharmaceutical Group Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see Jianmin Pharmaceutical Group Co Ltd operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Jianmin Pharmaceutical Group Co Ltd. See 600976 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CN¥114.34 Million | CN¥274.53 Million | CN¥100.67 Million | ▼ -70.2% |
| 2024 | 1.40x | CN¥327.06 Million | CN¥234.27 Million | CN¥120.29 Million | ▲ +164.2% |
| 2023 | 0.53x | CN¥141.81 Million | CN¥268.39 Million | CN¥64.50 Million | ▼ -20.5% |
| 2022 | 0.66x | CN¥143.44 Million | CN¥215.87 Million | CN¥67.96 Million | ▲ +45.5% |
| 2021 | 0.46x | CN¥118.37 Million | CN¥259.18 Million | CN¥55.99 Million | ▼ -67.0% |
| 2020 | 1.38x | CN¥173.75 Million | CN¥125.54 Million | CN¥45.58 Million | ▼ -28.2% |
| 2019 | 1.93x | CN¥143.57 Million | CN¥74.45 Million | CN¥69.31 Million | ▼ -10.4% |
| 2018 | 2.15x | CN¥136.82 Million | CN¥63.60 Million | CN¥42.37 Million | ▼ -62.3% |
| 2017 | 5.71x | CN¥200.93 Million | CN¥35.20 Million | CN¥41.93 Million | ▲ +448.5% |
| 2016 | 1.04x | CN¥118.48 Million | CN¥113.84 Million | CN¥29.42 Million | ▼ -51.3% |
| 2015 | 2.14x | CN¥103.55 Million | CN¥48.45 Million | CN¥29.75 Million | ▲ +724.1% |
| 2014 | 0.26x | CN¥26.77 Million | CN¥103.23 Million | CN¥26.77 Million | ▼ -50.8% |
| 2013 | 0.53x | CN¥23.90 Million | CN¥45.36 Million | CN¥23.90 Million | ▲ +476.8% |
| 2012 | 0.09x | CN¥8.97 Million | CN¥98.17 Million | CN¥8.97 Million | ▲ +153.3% |
| 2010 | 0.04x | CN¥5.41 Million | CN¥150.08 Million | CN¥5.41 Million | ▼ -83.4% |
| 2009 | 0.22x | CN¥14.50 Million | CN¥66.69 Million | CN¥14.50 Million | ▲ +175.5% |
| 2008 | 0.08x | CN¥8.69 Million | CN¥110.11 Million | CN¥8.69 Million | ▼ -73.3% |
| 2006 | 0.30x | CN¥16.61 Million | CN¥56.18 Million | CN¥16.61 Million | ▼ -97.9% |
| 2004 | 13.95x | CN¥57.64 Million | CN¥4.13 Million | CN¥57.64 Million | ▼ -40.3% |
| 2003 | 23.37x | CN¥97.88 Million | CN¥4.19 Million | CN¥97.88 Million | — |